# Intensity Modulated Radiation Therapy for Head and Neck Cancer

> **NCT00188877** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 44 (estimated)

## Conditions studied

- Nasopharyngeal Neoplasms

## Interventions

- **PROCEDURE:** intensity modulated radiation therapy
- **DRUG:** cisplatinium and fluorouracil - standard treatment

## Key facts

- **NCT ID:** NCT00188877
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2008-06
- **Final completion:** 2019-06
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2019-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188877, "Intensity Modulated Radiation Therapy for Head and Neck Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00188877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*